Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Diabetes & Metabolism Journal · 01.05.2025 · 49 (3) · 368-385
DOI: 10.4093/dmj.2025.0195 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.05.2025. Verfasst von Yeon Jin Roh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Epigenesis, Genetic, Metabolic Diseases, Liver. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Ministry of Education.
Abstract (Originalsprache)
The liver plays a fundamental role in metabolic homeostasis, integrating systemic fuel utilization with the progression of various metabolic diseases. Hepatic stellate cells (HSCs) are a key nonparenchymal cell type in the liver, which is essential for maintaining hepatic architecture in their quiescent state. However, upon chronic liver injury or metabolic stress, HSCs become activated, leading to excessive extracellular matrix deposition and pro-fibrotic signaling, ultimately positioning them as key players in liver pathology. Emerging evidence highlights the critical roles of metabolic reprogramming and epigenetic regulation in HSCs activation. HSCs activation is driven by both intrinsic fuel metabolism reprogramming and extrinsic metabolic cues from the microenvironment, while the metabolic intermediates actively reshape the epigenetic landscape, reinforcing fibrogenic transcriptional programs. In this review, we summarize recent advances in understanding how metabolic and epigenetic alterations drive HSCs activation, thereby shaping transcriptional programs that sustain fibrosis, and discuss potential therapeutic strategies to target these interconnected pathways in human metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Ministry of Education
Zitieren
APA
Roh, Y. J., Kim, H., & Choi, D. W. (2025). Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases. Diabetes & Metabolism Journal, 49(3), 368-385. https://doi.org/10.4093/dmj.2025.0195
Vancouver
Roh YJ, Kim H, Choi DW. Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases. Diabetes & Metabolism Journal. 2025;49(3):368-385. doi:10.4093/dmj.2025.0195
BibTeX
@article{Roh2025,
author = {Roh, Yeon Jin and Kim, Hyeonki and Choi, Dong Wook},
title = {Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases},
journal = {Diabetes & Metabolism Journal},
year = {2025},
volume = {49},
number = {3},
pages = {368--385},
doi = {10.4093/dmj.2025.0195}
}
EUVIMED